Division 1.2 Assessment procedureF1
United Kingdom Repealed
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
- 1.2.1Animals as a source of material
- 1.2.2Geographical sourcing
- 1.2.3Nature of starting tissue
- 1.2.4Inactivation or removal of transmissible agents
- 1.2.5Quantities of animal starting tissues or derivatives required to produce one unit of the medical device
- 1.2.6Tissues or derivatives of animal origin coming into contact with the patients and users
- 1.2.7Route of administration